Teva Pharmaceutical Industries' Q4 2024 results ... The dual-action rescue inhaler program (DARI) is intended to treat up to 11 million patients in the US still dependent on single-dose albuterol ...

Teva Pharmaceutical Industries Limited develops ... UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic ...

Operator Hello, and welcome to the fourth quarter and full year 2024 Teva Pharmaceutical Industries ... Moving on to our dual action rescue inhaler program, very exciting program, very big program ...

While Momenta Pharmaceuticals and Novartis’ Sandoz ... for its asthma drug Advair thanks to the complexity of its inhaler device. Teva's challenge Although Teva is known as the world’s largest ...

Teva Pharmaceutical is one of the leading global ... complex generics and biosimilars usually come in injectables, inhalers, and other different forms that pose more challenges to other ...

Appellate courts issued a variety of notable intellectual property (IP) cases in 2024, including cases touching on Orange Book ...

has signed Teva Pharmaceuticals (NYSE: TEVA) to distribute its inhaler following its approval by... Download the free “New Cannabis Ventures” app on the iOS App Store or Google Play and get ...

Teva Pharmaceutical Industries Limited develops ... UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic ...

Aptar has a narrow economic moat, with durable switching costs in the Pharma business supported by intangible assets throughout the product portfolio from expertise in product regulation, design, and ...

A New Jersey federal judge agreed to modify a prior ruling so a settlement resolving Teva Pharmaceutical Industries Ltd.’s infringement suit over Cipla Ltd.’s generic version of its Qvar asthma ...

In its fourth quarter 2024 investor letter, Sound Shore Management emphasized stocks such as Teva Pharmaceutical Industries Limited (NYSE:TEVA). Headquartered in Tel Aviv, Israel, Teva ...